CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-15 | Gharib Samir M. President & CFO | Option exercise · Restricted Stock Units | −37,250 | 111,750 | ||
| 2023-12-15 | Szwarcberg Javier B. Chief Executive Officer | Option exercise | +111,000 | 145,705 | ||
| 2023-12-15 | Szwarcberg Javier B. Chief Executive Officer | Shares withheld for taxes | −38,384 | $1.66 | $64K | 107,321 |
| 2023-12-15 | Szwarcberg Javier B. Chief Executive Officer | Option exercise · Restricted Stock Units | −111,000 | 333,000 | ||
| 2023-12-14 | Charlton Ralph William III Chief Medical Officer | Grant or award · Restricted Stock Units | +212,800 | 212,800 | ||
| 2023-12-14 | Gharib Samir M. President & CFO | Grant or award · Restricted Stock Units | +308,000 | 308,000 | ||
| 2023-12-14 | Szwarcberg Javier B. Chief Executive Officer | Grant or award · Restricted Stock Units | +717,600 | 717,600 | ||
| 2023-11-26 | Szwarcberg Javier B. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-11-08 | Gharib Samir M. President & CFO | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2023-06-30 | Charlton Ralph William III Chief Medical Officer | Grant or award | +12,378 | $0.98 | $12K | 25,242 |
| 2023-06-30 | Szwarcberg Javier B. Chief Executive Officer | Grant or award | +20,000 | $0.98 | $20K | 34,705 |
| 2023-06-30 | Gharib Samir M. President & CFO | Grant or award | +10,484 | $0.98 | $10K | 66,302 |
| 2023-06-30 | Gharib Samir M. President & CFO | Option exercise | +75,000 | 141,302 | ||
| 2023-06-30 | Gharib Samir M. President & CFO | Shares withheld for taxes | −25,936 | $2.15 | $56K | 115,366 |
| 2023-06-30 | Gharib Samir M. President & CFO | Option exercise · Restricted Stock Units | −75,000 | 150,000 | ||
| 2023-05-25 | Ways Kirk Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-25 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-25 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-25 | O'Donnell Niall Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-25 | Muralidhar Bali Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 9 of 12 · 231 trades